Brenig Therapeutics
Latest round
- Series A
Last raised
- Jul 2024
Total raised
- $30M
Investors
- 4
About Brenig Therapeutics
operates as a provider of neurodegenerative disorder therapy for the healthcare industry. In July 2024, Brenig Therapeutics Inc. As of 2024, the firm operates in stealth mode. Brenig Therapeutics Inc. focuses on neurology-based drug development by leveraging artificial intelligence and machine learning platforms. The company specializes in small-molecule therapy development, such as BT-267, which is a small-molecule LRKK2 inhibitor for brain exposure and minimal peripheral exposure.
Who invested in Brenig Therapeutics
4 investors across 1 round
See all investors in Brenig Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jul 16, 2024
Amount
$30M
Investors
Questions about Brenig Therapeutics
Who invested in Brenig Therapeutics?
Brenig Therapeutics has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Brenig Therapeutics raised?
Brenig Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Brenig Therapeutics last raise money?
Brenig Therapeutics's most recent round on record is a Series A, in Jul 2024.
What does Brenig Therapeutics do?
operates as a provider of neurodegenerative disorder therapy for the healthcare industry.
Where is Brenig Therapeutics headquartered?
Brenig Therapeutics is headquartered in Dover, US.
Which VCs invest in companies like Brenig Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Brenig Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Brenig Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.